| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.099 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |